Russia rolls out first approved Covid-19 drug as infections pass 500,000

Russia rolls out first approved Covid-19 drug as infections pass 500,000 The first deliveries of the new antiviral agent,

 registered under the name Aviator, were made to some hospitals and clinics across the country, Russia’s R DIFF sovereign wealth fund said during a handout. Russia on Thursday extended a drug approved to treat patients plagued by the novel coronavirus, its state financial backer said, because the number of infections there surpassed half 1,000,000. The first deliveries of the new medicament, registered under the name Aviator, were made to some hospitals and clinics across the country, Russia’s R DIFF sovereign wealth fund said during a release. R DIFF has funded trials and incorporates a 50% share within the drug’s manufacturer Cheddar. other countries were still underway

There is currently no vaccine for Covid-19, the disease caused by the new coronavirus, and human trials of several existing antiviral drugs have yet to point out efficacy.Dmitriev on Thursday said over 10 countries had made requests for Avifavir supplies. Negotiations were underway to provide the drug to the majority of Russia’s regions, with seven of its over 80 regions receiving Thursday’s initial deliveries, Dmitriev added. With 502,436 cases, Russia has the third-highest number of infections within the world after Brazil and also us but encompasses a relatively low official toll of 6,532 - something that has been the main target of debate. The Moscow health department on Wednesday raised its price for May, citing changes within the way it determines the reason for death for patients tormented by other health problems.